The manufacturers of Nurofen will be fined $6 million for misleading consumers.
Earlier this year, the ACCC won its case against pharmaceutical giant Reckitt Benckiser over the company’s “specific pain” range.
The Federal Court found the products were misleading because they all contained the same active ingredient and did the same thing.
It handed the company a $1.7 million fine, but today that was increased to $6 million after the consumer watchdog appealed.
When lodging the appeal, ACCC chairman Rod Sims said the fine imposed would not deter companies from breaching consumer laws.
“It is disappointing a fine of $1.7 million was imposed for a company this size,” he said.
“It is not really going to catch people’s attention and send the deterrence message we need.”